Therapeutic CMV vaccine: promising Phase II trial.
D017322:Clinical Trials, Phase II as Topic; D003586:Cytomegalovirus Infections / Q000628:therapy*; D022482:Cytomegalovirus Vaccines / Q000008:administration & dosage / Q000276:immunology*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D016896:Treatment Outcome
D022482:Cytomegalovirus Vaccines